Neugebauer, a Brazilian native who recently co-drove with Formula 1 star Rubens Barrichello, currently holds the lap record ...

IT之家 3 月 8 日消息，汽车媒体 carscoops 今天（3 月 8 日）发布博文，报道称韩国豪华汽车品牌捷尼赛思（Genesis）正在开发一款全新的 LMDh 赛车，计划参加耐力赛事。 消息称该赛车将采用 V8 引擎，基于现代 WRC ...

Neugebauer, a Brazilian native who recently co-drove with Formula One star Rubens Barrichello, currently holds the lap record ...

DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...

36 Enseva/Diercks Ltd./TC Fab Ford Mustang) leading the event from green to checkers. Lee Saunders (No. 84 Landsearch LLC Dodge Viper) ran second for most of the event, but following the mid-race ...

A fight is brewing over California’s ability to set its own vehicle emissions rules. The Golden State long has had that power thanks to an EPA waiver, which was renewed last December by the Biden ...

With a new Toyota/Lexus GT3-level car anticipated for 2026, this looks to be the RC F’s last year in IMSA, and we’re almost upon the Mobil 1 Twelve Hours of Sebring, which is the last race it won in ...

Last year, NASA canceled the VIPER (“Volatiles Investigating Polar Exploration Rover”) in a move that scandalized proponents of a return to the moon. The space agency was just $84 million ...

13, 2025 that it has tested a mysterious new Long Range Precision Fire (LRPF) missile from a U.S. Marine Corps AH-1Z Viper in Nov. 2024 at the Yuma Proving Ground, Arizona. In the only photo ...

The Iron Dames has retained Michelle Gatting, Rahel Frey and Sarah Bovy for the remaining four IMSA Endurance Cup races of the 2025 season. As having competed in the 2024 IMSA SportsCar Championship, ...

AutoNET IMSA - Winners again Posted: January 31, 2025 | Last updated: January 31, 2025 Porsche Penske Motorsport has clinched its second consecutive victory at the 24 Hours of Daytona. Last year's ...

IMSA-101 is under clinical development by ImmuneSensor Therapeutics and currently in Phase II for Gastroesophageal (GE) Junction Carcinomas. According to GlobalData, Phase II drugs for ...